PTPI (OTC)
PETROS PHARM INC
$0.006000
-0.001000 (-14.29%)
Prev close: $0.007000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Shulman John David
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.12M
- Employees
- 24
- P/E (TTM)
- —
- P/B (TTM)
- 0.42
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $249.29K |
| Benefits Costs and Expenses | $4.54M |
| Costs And Expenses | $4.54M |
| Operating Expenses | $4.21M |
| Selling, General, and Administrative Expenses | $4.21M |
| Operating Income/Loss | -$4.21M |
| Income/Loss From Continuing Operations After Tax | -$4.29M |
| Income/Loss From Continuing Operations Before Tax | -$4.29M |
| Interest Income/Expense After Provision For Losses | $249.29K |
| Interest Income/Expense Operating, Net | $249.29K |
| Net Income/Loss | -$3.79M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$6.97M |
| Net Income/Loss Attributable To Parent | $3.19M |
| Net Income/Loss Available To Common Stockholders, Basic | $3.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$0.96 |
| Diluted Earnings Per Share | -$0.96 |
| Basic Average Shares | 119,221,305 |
| Diluted Average Shares | 119,221,305 |
| Assets | $4.39M |
| Current Assets | $4.39M |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.62M |
| Current Liabilities | $2.62M |
| Accounts Payable | $133.30K |
| Other Current Liabilities | $2.49M |
| Noncurrent Liabilities | $0.00 |
| Equity | $1.77M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.77M |
| Liabilities And Equity | $4.39M |
| Net Cash Flow From Operating Activities | -$5.86M |
| Net Cash Flow From Operating Activities, Continuing | -$4.03M |
| Net Cash Flow | -$784.27K |
| Net Cash Flow, Continuing | -$784.27K |
| Comprehensive Income/Loss | -$3.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.79M |
| Other Comprehensive Income/Loss | $0.00 |